Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pediatrix Medical Group, Inc. Director's Dealing 2021

May 14, 2021

31972_dirs_2021-05-14_47537679-9f2b-4ddd-b3d5-339794670196.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDNAX, INC. (MD)
CIK: 0000893949
Period of Report: 2021-05-12

Reporting Person: MEDEL ROGER MD (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-12 Common Stock A 4885 $0.00 Acquired 1322542 Direct

Footnotes

F1: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 12, 2022.